ApTOLL

· aptaTargets S.L.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ApTOLL, covering 2022-10-21 to 2022-10-21. Get the full timeline:

Most recent: Clinical Trial Update: Phase Ib/IIa Clinical Study of ApTOLL for the Treatment of Acute Ischemic Stroke [Phase 1, Phase 2]